BMC Geriatrics (Nov 2023)

Effect of 4-weeks exercise program using wearable hip-assist robot (EX1) in older adults: one group pre- and post- test

  • Jang-hoon Shin,
  • Naeun Byeon,
  • Heeju Yu,
  • Geonhyang Yun,
  • Hyunjin Kim,
  • Seungyeop Lim,
  • Dongwoo Kim,
  • Hwang-Jae Lee,
  • Wan-hee Lee

DOI
https://doi.org/10.1186/s12877-023-04423-x
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Background Older adults have muscle loss and are at risk of falling. Recently, research in the healthcare field has been actively conducted, and Samsung Electronics has developed EX1, a hip joint assisted robot for exercise. This study aimed to verify the effect of a 4-week combined exercise program applying EX1 on older adults. Methods This study design was an evaluator-blinded, pre- and post-test. A total of 21 older adults performed an exercise program consisting of walking and fitness wearing EX1 for 50 min per session, 3 days a week during the 4-week exercise period. For comparison before and after participating in the exercise program, the spatio-temporal parameters, pelvic movement were analyzed by G-Walk, functional outcomes were evaluated by TUG, muscle power were evaluated by RUSI, and waist-hip ratio were analyzed by Inbody. All data were analyzed before and after exercise using paired t-test, and the statistical significance level was set at 0.05. Results In spatio-temporal parameters, stride length showed statistically significant improvements after exercise with EX1 (P < 0.01). Also, propulsion showed statistically significant improvements after exercise with EX1 (P < 0.01) Regarding changes of the gait posture, there was a statistically significant improvement in pelvic movement (P < 0.05). In the functional evaluation, the time required was statistically significantly reduced in the timed up and go test (P < 0.05). Conclusion These results demonstrate that a 4-week exercise program with EX1 was effective in improving the functional gait of the elderly. However, because the participants were 21, it is difficult to generalize the results. Trial registration Clinical Research Information Service, KCT0007367. Registered 08/06/2022.

Keywords